MINNEAPOLIS--(BUSINESS WIRE)--April 24, 2006--MGI PHARMA, INC. (Nasdaq:MOGN - News), an oncology- and acute care- focused biopharmaceutical company, today announced the appointment of William F. Spengler as Senior Vice President and Chief Financial Officer. Mr. Spengler was previously Senior Vice President, International and Corporate Development at MGI PHARMA and succeeds James Hawley, who has left the company to pursue other interests.
